Navigation Links
Fralex reaches 100th patient milestone in fibromyalgia study
Date:3/10/2008

core ("NRS") pain scores between week 12 and baseline.

With success in achieving the primary safety and efficacy endpoints, the data from the RELIEF study will form part of a Premarket Approval ("PMA") submission to the FDA. Fralex is seeking to be the first company to market a medical device in the U.S. and Canada which is indicated for the treatment of chronic pain associated with fibromyalgia.

About FRALEX:

FRALEX is a medical technology company focused on developing and commercializing Complex Neural Pulse or CNP(TM), a novel neuromodulation therapeutic technology for chronic pain, which utilizes specifically designed, low frequency electromagnetic pulses. FRALEX is proceeding with its FDA- and Health Canada-approved pivotal clinical trial (the "RELIEF" trial) to evaluate the safety and effectiveness of this technology in the treatment of chronic pain associated with fibromyalgia. The trial is to be conducted in 2007 and 2008 at leading medical centres within the U.S. and Canada. For more information on FRALEX, please visit http://www.fralex.com; further details on the RELIEF trial are posted on http://www.clinicaltrials.gov.

Certain statements contained in this release containing words like "believe", "intend", "may", "expect", and other similar expressions, are forward-looking statements that involve a number of risks and uncertainties. Factors that could cause actual results to differ materially from those projected in the Company's forward-looking statements include the following: market acceptance of Company's technologies and products; the ability to obtain financing; Company's financial and technical resources relative to those of its competitors; Company's ability to keep up with rapid technological change; government regulation of therapeutic technologies; the Company's ability to enforce its intellectual property right
'/>"/>

SOURCE Fralex Therapeutics Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Addrenex Pharmaceuticals Reaches Milestone with Filing of NDA for First Product, CloniBID, to Treat Hypertension
2. Genmab Reaches Milestones in Ofatumumab Collaboration
3. Pharsights Reporting and Analysis Services Business Reaches Quality Assurance Milestone
4. Luminex Corporation Reaches Settlement With Rules Based Medicine, Inc.
5. Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
6. Genzyme Launches Renvela(R) in the U.S. for Dialysis Patients
7. CHOP-Zevalin(R) Investigational Regimen Produces 95% Complete Remission and 75% Estimated Two Year Progression-Free Survival in Elderly Patients with Diffuse Large B-cell Lymphoma
8. NicOx Initiates Two Large ABPM Studies for Naproxcinod in Hypertensive Patients with Osteoarthritis
9. FDA Approves PRISTIQ(TM) for the Treatment of Adult Patients with Major Depressive Disorder
10. Anadys Pharmaceuticals Commences Phase I Clinical Trial of ANA773 in Cancer Patients
11. Artromick Aligns with McKesson to Enhance Medication Safety at the Patients Bedside
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... 2014 METTLER TOLEDO’s newly improved XS ... balances as well as a dual range ... the new SmartPan™ weighing pan delivers results up to ... all balances, ergonomic design details mean users no longer ... for long periods in front of the balance. Barbara ...
(Date:10/1/2014)...  Spherix Incorporated (Nasdaq: SPEX) -- an intellectual property development ... intellectual property, announced today that the Markman hearing ... the U.S. District Court for the Northern District ... rescheduled for November 10, 2014.  This hearing was ... Order setting the Markman date was received after ...
(Date:10/1/2014)... Today the National Institutes of ... for the Brain Research through Advancing Innovative Neurotechnologies ... and revolutionize new methods of understanding the complexities ... This first round of grants totaling $46 million ... to more than 100 investigators in 15 states ...
(Date:10/1/2014)... 2014 Slone Partners , a ... IT, and Laboratory Testing industries, reported a 120% increase ... director level and above from July 2013 to July ... top of rapid breakthroughs in diagnostics, reimbursement has failed ... have been forced to fold, consolidate, or carry on ...
Breaking Biology Technology:METTLER TOLEDO’s XS Balance Line Delivers Performance and Ergonomics To Safeguard Health in the Workplace 2METTLER TOLEDO’s XS Balance Line Delivers Performance and Ergonomics To Safeguard Health in the Workplace 3Markman Hearing Date for VTech and Uniden Litigation Now Set for November 10, 2014 2NIH Awards 15 Grants to CHI Members for BRAIN Initiative Research 2NIH Awards 15 Grants to CHI Members for BRAIN Initiative Research 3Slone Partners Meets Growing Demand as Industry Focuses on Reimbursement & Regulation 2
... Nov. 28 Life scientists are highly,engaged users ... preliminary,results of a worldwide study of more than ... provider of market research services. The,survey, co-sponsored by ... business-to business advertising and marketing,agency, found that 77 ...
... antibody,engineering company developing novel antibodies and antibody fragments,based on ... raised EUR 3.0 million from Novo A/S in a ... by Aescap Venture and Atlas Venture.,After this Second Closing, ... EUR 9.0 million. In total, the Company has raised ...
... testing demonstrate ANAVEX 1-41 has significant ... neuroprotective and anti-amnesic benefits, GENEVA, Nov. ... is pleased to announce promising developments with,ANAVEX 1-41, the ... animal studies, ANAVEX 1-41 prevented oxidative stress,which damages and ...
Cached Biology Technology:Scientists Using Social Media to Inform Lab Purchasing Decisions 2Antibody Engineering Company f-star Raises EUR 3.0 Million in a Second Closing of its Series A Financing Round From Novo A/S 2Antibody Engineering Company f-star Raises EUR 3.0 Million in a Second Closing of its Series A Financing Round From Novo A/S 3Anavex advances drug candidate for treatment of Alzheimer's disease 2Anavex advances drug candidate for treatment of Alzheimer's disease 3Anavex advances drug candidate for treatment of Alzheimer's disease 4Anavex advances drug candidate for treatment of Alzheimer's disease 5
(Date:9/29/2014)... A species of gut bacteria called Clostridium ramosum , ... weight. The work is published this week in mBio ... Microbiology. , A research team from the German Institute ... human gut bacteria including C. ramosum gained weight ... C. ramosum were less obese even when consuming ...
(Date:9/29/2014)... Monday, September 29: Between 1970 and 2010 populations ... the globe dropped 52 percent, says the 2014 ... Fund (WWF). This biodiversity loss occurs disproportionately in ... of high-income countries. , In addition to the ... point to other warning signs about the overall ...
(Date:9/29/2014)... should use ventilation when cooking with a gas stove, ... new study showed an association between gas kitchen stove ... "In homes where a gas stove was used without ... than in homes where a gas stove was used ... the College of Public Health and Human Sciences at ...
Breaking Biology News(10 mins):Gut bacteria promote obesity in mice 2Half of global wildlife lost, says new WWF report 2Childhood asthma linked to lack of ventilation for gas stoves, OSU study shows 2Childhood asthma linked to lack of ventilation for gas stoves, OSU study shows 3
... from the Asian continent, Drosophila suzukii has only been ... into the Iberian Peninsula, it accelerated towards the north of Europe ... are cherries and red fruits but any type of fruit is ... a threat to the fruit of more and more European countries. ...
... 2012)A rapid increase in shipping in the formerly ice-choked ... risk to the region,s marine mammals and the local ... cultural identity, according to an Alaska Native groups and ... workshop. , The workshopwhich ran from March 12-14examined ...
... Naval Research (ONR) will bring its technologically advanced fuel ... Pacific Operational Science & Technology (S&T) Conference in Honolulu, ... strategic area for the Navy and Marine Corps," said ... worldwide leaders in S&T at this event to discuss ...
Cached Biology News:An invasive Asian fly is taking over European fruit 2Increase in Arctic shipping poses risk to marine mammals 2Increase in Arctic shipping poses risk to marine mammals 3Increase in Arctic shipping poses risk to marine mammals 4ONR outreach focuses on Pacific total force 2
Unit Definition: 1 U corresponds to the amount of enzyme which produces 1 mol protons per minute at pH 5.5 and 30C (peptin from citrus peel, Fluka-No. 76280, as substrate)...
ANTI STENOTROPHOMONAS MALTOPHILIA...
... Features Convenient platform for tube handling ... 96 x 0.2ml V-bottom tubes - ... Plates - Thermo-Fast® 96 Non-Skirted Plate ... - 48 x 0.5ml Thermo-Tubes Multiple workstations ...
... 96 well Magnetic-Ring Stand is designed for ... U-bottom microplates. The stand has a plastic ... microtiter plate footprint. The use of 96 ... and easy magnetic separation. With this magnetic ...
Biology Products: